The Part Nobody Tells You About GLP-1 Medications
You found the drug. Your doctor wrote the prescription. And then you hit the wall that stops more people than side effects ever could: the insurance company says no. If that sounds familiar, this video from A Pound of Cure walks through the exact process for getting GLP-1 medications covered, step by step, with the kind of specificity that actually helps.
The GLP-1 insurance problem is not a bug. It is the system working exactly as designed. Insurance companies are in the business of not paying for things, and GLP-1 medications, which cost $800 to $1,600 per month at list price, are the most expensive new drug category to hit the market in years. Insurers have every financial incentive to deny coverage, and they have built multi-layered systems to do exactly that. Understanding those systems is the first step to beating them.
Why Your Claim Got Denied (And Why That Is Normal)
The first thing to understand is that an initial denial is standard operating procedure. Somewhere between 40% and 60% of initial GLP-1 prior authorization requests get denied, depending on the insurer. This does not mean you are disqualified. It means the insurance company is running its standard playbook, which is to deny first and see who goes away. A huge percentage of people accept the denial and never appeal. The insurance company is counting on that.
Denials typically fall into a few categories. The most common is failure to meet step therapy requirements. This means your insurer wants documentation that you tried and failed other treatments before they will pay for a GLP-1. Those prior treatments usually include lifestyle modification (diet and exercise) for a defined period, and sometimes older, cheaper medications like metformin or orlistat. Even if you have already done all of these things, the insurer needs it documented in a specific way.
The second common reason is BMI criteria. Most insurers require a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, sleep apnea). If your chart does not clearly document both your BMI and the comorbidity, the claim gets denied even if you clearly qualify.
The third reason is the specific drug versus formulary issue. Your insurer might cover Wegovy but not Ozempic for weight loss (since Ozempic is approved for diabetes, not obesity). Or they might cover Zepbound but not Mounjaro for the same reason. Getting the right drug name matched to the right diagnosis code matters more than it should.
Building Your Prior Authorization Package
The video breaks down exactly what should go into a prior authorization request, and this is where most people leave money on the table. A weak PA request gets denied. A strong one gets approved. The difference is documentation.
Start with your weight history. Insurance companies want to see that obesity is a chronic condition, not a temporary fluctuation. If you have documented weights in your medical record going back years showing a consistent pattern, include that data. If your PCP has been noting your weight at annual physicals, that record is gold.
Next, document your prior treatment attempts. Did you work with a dietitian? Include the records. Did you try a structured diet program? Document the dates, the program, and the outcome. Did you try metformin or orlistat? Include the prescription records and the reason you stopped (whether it was inefficacy, side effects, or both). The key is creating a paper trail that shows you have made good-faith efforts with lower-cost interventions and they were not sufficient.
Document your comorbidities with specific diagnostic codes. Do not just write hypertension. Include the ICD-10 code (I10), the date of diagnosis, current medications, and most recent lab values. For type 2 diabetes, include HbA1c values. For sleep apnea, include sleep study results. For dyslipidemia, include lipid panels. The more specific and clinical your documentation, the harder it is for a reviewer to find a reason to deny.
The Appeals Process: Where Persistence Pays Off
If your prior authorization gets denied, you have the right to appeal. Most insurers offer two levels of internal appeal, followed by an external review by an independent third party. The success rates at each level tell an interesting story.
Internal appeal success rates for GLP-1 medications run between 30% and 50%, depending on the insurer and the quality of the appeal letter. External review success rates are significantly higher, often 50-70%, because the reviewer is independent and has no financial stake in the outcome. The people who get their GLP-1 medications covered are usually the ones willing to go through two or three rounds of appeals.
The appeal letter itself matters enormously. A form letter from your doctor that says please approve this medication is not enough. An effective appeal letter includes a clinical summary of the patient (age, BMI history, comorbidities), a review of prior treatment attempts and their outcomes, a clinical rationale for why GLP-1 therapy is medically necessary for this specific patient, and references to published clinical evidence supporting the use of GLP-1 medications for the patient's condition.
Some physicians will write this letter themselves. Others will ask you to draft it or will use a template. If you are drafting it yourself, the video recommends structuring it as a medical narrative that reads like a case study. The person reviewing your appeal is usually a physician or nurse working for the insurance company. Speak their language.
Alternative Coverage Pathways
The video also covers options beyond traditional insurance coverage that many people do not know about. Manufacturer savings programs are the most accessible. Novo Nordisk (maker of Ozempic and Wegovy) and Eli Lilly (maker of Mounjaro and Zepbound) both offer savings cards that can reduce your out-of-pocket cost to $25-$150 per month. These programs have eligibility requirements and usually exclude people on government insurance (Medicare, Medicaid, Tricare), but for commercially insured patients, they can make the cost manageable even without full insurance coverage.
Employer benefit negotiations are another avenue. If you work for a company that self-insures (many large employers do), the decision about whether to cover GLP-1 medications is made by your employer, not by an insurance company. Some employees have successfully petitioned their HR departments to add GLP-1 coverage to their benefits package. This works best at companies that are already investing in employee wellness programs, because the long-term cost savings from reduced obesity-related healthcare claims can offset the drug costs.
Compounding pharmacies offer another option, particularly for semaglutide. During the FDA-recognized shortage, compounding pharmacies have been legally allowed to produce compounded versions of semaglutide at significantly lower cost, typically $200-$400 per month. The availability and legality of compounded semaglutide depends on the ongoing shortage status, so this pathway may or may not be available depending on when you are reading this.
The Timeline You Should Expect
Getting GLP-1 coverage approved is not a quick process. A realistic timeline looks something like this: two to four weeks for the initial prior authorization request and decision, two to four weeks for a first-level appeal if denied, another two to four weeks for a second-level appeal, and potentially six to eight weeks for an external review. From start to finish, you could be looking at three to four months if you need to go through the full appeals process.
Plan accordingly. If you want to start GLP-1 therapy and anticipate insurance resistance, begin the authorization process immediately. Do not wait until you are frustrated with other approaches. Start the PA request at the same time you are trying lifestyle interventions. By the time you have documentation of those interventions, the insurance process may be further along.
Your Step-by-Step Action Plan
First, call your insurance company and ask specifically whether GLP-1 medications for obesity or weight management are covered under your plan, and if so, which specific drugs. Get the person's name and the call reference number. This saves time later if there is a dispute about what you were told.
Second, ask your doctor to submit a prior authorization. Bring your own documentation: weight history, diet program records, exercise logs, anything that demonstrates prior treatment attempts. Do not rely on your doctor's office to have all of this. They see hundreds of patients. You need to be your own advocate.
Third, if denied, appeal immediately. Do not let more than a few days pass. There are usually strict timelines for filing appeals (30-60 days in most cases), and the clock starts ticking from the denial date.
Fourth, if internal appeals fail, request an external review. This is your strongest card. Independent reviewers approve GLP-1 claims at significantly higher rates than internal reviewers.
Fifth, while waiting, explore manufacturer savings programs, compounding pharmacies, and employer benefit options. Do not let the insurance process be your only path. Parallel processing saves time.
One additional strategy the video mentions that many people overlook: document everything in writing. Every phone call to your insurance company, note the date, time, representative name, and reference number. Every denial letter, keep it in a file. Every appeal you submit, keep a copy with the date it was sent. Insurance disputes sometimes escalate to state insurance commissioner complaints or even legal proceedings, and having a thorough paper trail makes your case dramatically stronger. The people who successfully navigate this process treat it like a project with milestones and documentation, not like a single phone call that either works or does not.